# MSH2

> Mediated Wiki article. Canonical URL: https://mediated.wiki/source/MSH2
> Markdown URL: https://mediated.wiki/source/MSH2.md
> Source: https://en.wikipedia.org/wiki/MSH2
> Source revision: 1354590971
> License: Creative Commons Attribution-ShareAlike 4.0 International (https://creativecommons.org/licenses/by-sa/4.0/)

Protein-coding gene in the species Homo sapiens

MSH2 Available structures PDB Ortholog search: PDBe RCSB List of PDB id codes 2O8B, 2O8C, 2O8D, 2O8E, 2O8F, 3THW, 3THX, 3THY, 3THZ Identifiers Aliases MSH2, mutS homolog 2, COCA1, FCC1, HNPCC, HNPCC1, LCFS2, hMMRCS2, MSH-2 External IDs OMIM: 609309; MGI: 101816; HomoloGene: 210; GeneCards: MSH2; OMA:MSH2 - orthologs Gene location (Human) Chr. Chromosome 2 (human)[1] Band 2p21-p16.3 Start 47,403,067 bp[1] End 47,663,146 bp[1] Gene location (Mouse) Chr. Chromosome 17 (mouse)[2] Band 17 E4|17 57.87 cM Start 87,979,758 bp[2] End 88,031,141 bp[2] RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in secondary oocyte ventricular zone ganglionic eminence gonad retinal pigment epithelium testicle middle frontal gyrus Brodmann area 10 rectum cerebellar hemisphere Top expressed in primitive streak saccule epiblast otic placode otic vesicle tail of embryo somite zygote secondary oocyte abdominal wall More reference expression data BioGPS More reference expression data Gene ontology Molecular function DNA binding nucleotide binding protein homodimerization activity mismatched DNA binding dinucleotide insertion or deletion binding ADP binding centromeric DNA binding oxidized purine DNA binding single-stranded DNA binding damaged DNA binding ATPase activity protein C-terminus binding protein binding single thymine insertion binding four-way junction DNA binding MutLalpha complex binding enzyme binding double-stranded DNA binding dinucleotide repeat insertion binding ATP binding protein kinase binding magnesium ion binding single guanine insertion binding guanine/thymine mispair binding Y-form DNA binding heteroduplex DNA loop binding double-strand/single-strand DNA junction binding ATP-dependent activity, acting on DNA chromatin binding Cellular component MutSbeta complex membrane MutSalpha complex nucleoplasm mismatch repair complex nucleus chromosome Biological process negative regulation of neuron apoptotic process germ cell development male gonad development postreplication repair determination of adult lifespan in utero embryonic development cellular response to DNA damage stimulus oxidative phosphorylation maintenance of DNA repeat elements positive regulation of helicase activity somatic recombination of immunoglobulin gene segments intrinsic apoptotic signaling pathway in response to DNA damage negative regulation of DNA recombination somatic recombination of immunoglobulin genes involved in immune response DNA mismatch repair B cell differentiation B cell mediated immunity DNA repair positive regulation of isotype switching to IgA isotypes positive regulation of isotype switching to IgG isotypes double-strand break repair meiotic gene conversion response to X-ray response to UV-B somatic hypermutation of immunoglobulin genes mitotic intra-S DNA damage checkpoint signaling intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator negative regulation of reciprocal meiotic recombination isotype switching protein localization to chromatin DNA recombination Sources:Amigo / QuickGO Orthologs Species Human Mouse Entrez 4436 17685 Ensembl ENSG00000095002 ENSMUSG00000024151 UniProt P43246 P43247 RefSeq (mRNA) NM_000251 NM_001258281 NM_008628 RefSeq (protein) NP_000242 NP_001245210 NP_032654 Location (UCSC) Chr 2: 47.4 – 47.66 Mb Chr 17: 87.98 – 88.03 Mb PubMed search [3] [4] Wikidata View/Edit Human View/Edit Mouse

**DNA mismatch repair protein Msh2** also known as **MutS homolog 2** or **MSH2** is a [protein](/source/Protein) that in humans is encoded by the *MSH2* [gene](/source/Gene), which is located on [chromosome 2](/source/Chromosome_2). MSH2 is a [tumor suppressor gene](/source/Tumor_suppressor_gene) and more specifically a [caretaker gene](/source/Caretaker_gene) that codes for a [DNA mismatch repair](/source/DNA_mismatch_repair) (MMR) protein, MSH2, which forms a [heterodimer](/source/Heterodimer) with [MSH6](/source/MSH6) to make the human MutSα mismatch repair complex. It also dimerizes with [MSH3](/source/MSH3) to form the MutSβ DNA repair complex. MSH2 is involved in many different forms of [DNA repair](/source/DNA_repair), including [transcription-coupled repair](/source/Transcription-coupled_repair),[5] [homologous recombination](/source/Homologous_recombination),[6] and [base excision repair](/source/Base_excision_repair).[7]

Mutations in the MSH2 gene are associated with [microsatellite instability](/source/Microsatellite_instability) and some cancers, especially with [hereditary nonpolyposis colorectal cancer](/source/Hereditary_nonpolyposis_colorectal_cancer) (HNPCC). At least 114 disease-causing mutations in this gene have been discovered.[8]

## Clinical significance

[Hereditary nonpolyposis colorectal cancer](/source/Hereditary_nonpolyposis_colorectal_cancer) (HNPCC), sometimes referred to as Lynch syndrome, is inherited in an [autosomal dominant](/source/Autosomal_dominant) fashion, where inheritance of only one copy of a mutated mismatch repair gene is enough to cause disease [phenotype](/source/Phenotype). Mutations in the MSH2 gene account for 40% of genetic alterations associated with this disease and is the leading cause, together with MLH1 mutations.[9] Mutations associated with HNPCC are broadly distributed in all domains of MSH2, and hypothetical functions of these mutations based on the crystal structure of the MutSα include [protein–protein interactions](/source/Protein%E2%80%93protein_interactions), [stability](/source/Chemical_stability), [allosteric regulation](/source/Allosteric_regulation), MSH2-MSH6 interface, and [DNA binding](/source/DNA-binding_domain).[10] Mutations in MSH2 and other mismatch repair genes cause DNA damage to go unrepaired, resulting in an increase in mutation frequency. These mutations build up over a person's life that otherwise would not have occurred had the DNA been repaired properly.

## Microsatellite instability

The viability of MMR genes including *MSH2* can be tracked via [microsatellite](/source/Microsatellite) instability, a biomarker test that analyzes short sequence repeats which are very difficult for cells to replicate without a functioning mismatch repair system. Because these sequences vary in the population, the actual number of copies of short sequence repeats does not matter, just that the number the patient does have is consistent from tissue to tissue and over time. This phenomenon occurs because these sequences are prone to mistakes by the DNA replication complex, which then need to be fixed by the mismatch repair genes. If these are not working, over time either duplications or deletions of these sequences will occur, leading to different numbers of repeats in the same patient.

71% of HNPCC patients show microsatellite instability.[11] Detection methods for microsatellite instability include polymerase chain reaction (PCR) and immunohistochemical (IHC) methods, polymerase chain checking the DNA and immunohistochemical surveying mismatch repair protein levels. "Currently, there are evidences that universal testing for MSI starting with either IHC or PCR-based MSI testing is cost effective, sensitive, specific and is generally widely accepted."[12]

## Role in mismatch repair

In eukaryotes from yeast to humans, MSH2 dimerizes with MSH6 to form the MutSα complex,[13] which is involved in base mismatch repair and short insertion/deletion loops.[14] MSH2 heterodimerization stabilizes MSH6, which is not stable because of its N-terminal disordered domain. Conversely, MSH2 does not have a nuclear localization sequence ([NLS](/source/Nuclear_localization_sequence)), so it is believed that MSH2 and MSH6 dimerize in the [cytoplasm](/source/Cytoplasm) and then are imported into the [nucleus](/source/Cell_nucleus) together.[15] In the MutSα dimer, MSH6 interacts with the DNA for mismatch recognition while MSH2 provides the stability that MSH6 requires. MSH2 can be imported into the nucleus without dimerizing to MSH6, in this case, MSH2 is probably dimerized to MSH3 to form MutSβ.[16] MSH2 has two interacting domains with MSH6 in the MutSα heterodimer, a DNA interacting domain, and an ATPase domain.[17]

The MutSα dimer scans double stranded DNA in the nucleus, looking for mismatched bases. When the complex finds one, it repairs the mutation in an [ATP](/source/Adenosine_triphosphate) dependent manner. The MSH2 domain of MutSα prefers [ADP](/source/Adenosine_diphosphate) to ATP, with the MSH6 domain preferring the opposite. Studies have indicated that MutSα only scans DNA with the MSH2 domain harboring ADP, while the MSH6 domain can contain either ADP or ATP.[18] MutSα then associates with MLH1 to repair the damaged DNA.

MutSβ is formed when MSH2 complexes with MSH3 instead of MSH6. This dimer repairs longer insertion/deletion loops than MutSα.[19] Because of the nature of the mutations that this complex repairs, this is probably the state of MSH2 that causes the microsatellite instability phenotype. Large DNA insertions and deletions intrinsically bend the DNA double helix. The MSH2/MSH3 dimer can recognize this topology and initiate repair. The mechanism by which it recognizes mutations is different as well, because it separates the two DNA strands, which MutSα does not.[20]

## Double-strand break repair

Msh2 modulates accurate [homologous recombination](/source/Homologous_recombination), a prominent [DNA double-strand break repair](/source/DNA_repair) pathway in mammalian [chromosomes](/source/Chromosome).[21] Repair of DNA double-strand breaks by accurate homologous recombination predominates over the inaccurate double-strand break repair pathway of "non-homologous end joining" in hamster, mouse and human somatic cells.[21]

## Interactions

MSH2 has been shown to [interact](/source/Protein%E2%80%93protein_interaction) with:

- [ATR](/source/Ataxia_telangiectasia_and_Rad3_related),[22][23]

- [BRCA1](/source/BRCA1),[24]

- [CHEK2](/source/CHEK2),[25][26]

- [EXO1](/source/Exonuclease_1),[27][28][29]

- [MAX](/source/MAX_(gene)),[30]

- [MSH3](/source/MSH3),[17][22][31][32]

- [MSH6](/source/MSH6),[17][22][24][31][32] and

- [p53](/source/P53).[33]

## Epigenetic MSH2 deficiencies in cancer

DNA damage appears to be the primary underlying cause of cancer,[34] and deficiencies in expression of DNA repair genes appear to underlie many forms of cancer.[35][36] If DNA repair is deficient, DNA damage tends to accumulate. Such excess DNA damage may increase [mutations](/source/Mutation) due to error-prone [translesion synthesis](/source/Mutation#Error-prone_replication_bypass) and error prone repair (see e.g. [microhomology-mediated end joining](/source/Microhomology-mediated_end_joining)). Elevated DNA damage may also increase [epigenetic](/source/Epigenetics) alterations due to errors during DNA repair.[37][38] Such mutations and epigenetic alterations may give rise to [cancer](/source/Cancer).

Reductions in expression of DNA repair genes (usually caused by epigenetic alterations) are very common in cancers, and are ordinarily much more frequent than mutational defects in DNA repair genes in cancers.[*[citation needed](https://en.wikipedia.org/wiki/Wikipedia:Citation_needed)*] (See [Frequencies of epimutations in DNA repair genes](/source/Cancer_epigenetics#Frequencies_of_epimutations_in_DNA_repair_genes).) In a study of *MSH2* in [non-small cell lung cancer](/source/Non-small-cell_lung_carcinoma) (NSCLC), no mutations were found while 29% of NSCLC had epigenetic reduction of *MSH2* expression.[39] In [acute lymphoblastoid leukemia](/source/Acute_lymphoblastic_leukemia) (ALL), no MSH2 mutations were found[40] while 43% of ALL patients showed MSH2 promoter methylation and 86% of relapsed ALL patients had MSH2 promoter methylation.[41] There were, however, mutations in four other genes in ALL patients that destabilized the MSH2 protein, and these were defective in 11% of children with ALL and 16% of adults with this cancer.[40]

Methylation of the promoter region of the *MSH2* gene is correlated with the lack of expression of the MSH2 protein in esophageal cancer,[42] in [non-small-cell lung cancer](/source/Non-small-cell_lung_carcinoma),[39][43] and in [colorectal cancer](/source/Colorectal_cancer).[44] These correlations suggest that methylation of the promoter region of the *MSH2* gene reduces expression of the MSH2 protein. Such promoter methylation would reduce DNA repair in the four pathways in which MSH2 participates: [DNA mismatch repair](/source/DNA_mismatch_repair), [transcription-coupled repair](/source/Transcription-coupled_repair)[5] [homologous recombination](/source/Homologous_recombination),[6][45][46] and [base excision repair](/source/Base_excision_repair).[7] Such reductions in repair likely allow excess DNA damage to accumulate and contribute to [carcinogenesis](/source/Carcinogenesis).

The frequencies of *MSH2* promoter methylation in several different cancers are indicated in the Table.

MSH2 promoter methylation in sporadic cancers Cancer Frequency of MSH2 promoter methylation Ref. Acute lymphoblastic leukemia 43% [41] Relapsed Acute lymphoblastic leukemia 86% [41] Renal cell carcinoma 51–55% [47][48] Esophageal squamous cell carcinoma 29–48% [42][49] Head and neck squamous-cell carcinoma 27–36% [50][51][52] Non-small cell lung cancer 29–34% [39][43] Hepatocellular carcinoma 10–29% [53] Colorectal cancer 3–24% [44][54][55][56] Soft-tissue sarcoma 8% [57]

## See also

- [Mismatch repair#MutS homologs](/source/Mismatch_repair#MutS_homologs)

## References

1. ^ [***a***](#cite_ref-refGRCh38Ensembl_1-0) [***b***](#cite_ref-refGRCh38Ensembl_1-1) [***c***](#cite_ref-refGRCh38Ensembl_1-2) [GRCh38: Ensembl release 89: ENSG00000095002](http://May2017.archive.ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000095002) – [Ensembl](/source/Ensembl_genome_database_project), May 2017

1. ^ [***a***](#cite_ref-refGRCm38Ensembl_2-0) [***b***](#cite_ref-refGRCm38Ensembl_2-1) [***c***](#cite_ref-refGRCm38Ensembl_2-2) [GRCm38: Ensembl release 89: ENSMUSG00000024151](http://May2017.archive.ensembl.org/Mus_musculus/Gene/Summary?db=core;g=ENSMUSG00000024151) – [Ensembl](/source/Ensembl_genome_database_project), May 2017

1. **[^](#cite_ref-3)** ["Human PubMed Reference:"](https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Link&LinkName=gene_pubmed&from_uid=4436). *National Center for Biotechnology Information, U.S. National Library of Medicine*.

1. **[^](#cite_ref-4)** ["Mouse PubMed Reference:"](https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Link&LinkName=gene_pubmed&from_uid=17685). *National Center for Biotechnology Information, U.S. National Library of Medicine*.

1. ^ [***a***](#cite_ref-Mellon_5-0) [***b***](#cite_ref-Mellon_5-1) Mellon I, Rajpal DK, Koi M, Boland CR, Champe GN (April 1996). ["Transcription-coupled repair deficiency and mutations in human mismatch repair genes"](https://zenodo.org/record/1231074). *Science*. **272** (5261): 557–60. [Bibcode](/source/Bibcode_(identifier)):[1996Sci...272..557M](https://ui.adsabs.harvard.edu/abs/1996Sci...272..557M). [doi](/source/Doi_(identifier)):[10.1126/science.272.5261.557](https://doi.org/10.1126%2Fscience.272.5261.557). [PMID](/source/PMID_(identifier)) [8614807](https://pubmed.ncbi.nlm.nih.gov/8614807). [S2CID](/source/S2CID_(identifier)) [13084965](https://api.semanticscholar.org/CorpusID:13084965).

1. ^ [***a***](#cite_ref-Wind_6-0) [***b***](#cite_ref-Wind_6-1) de Wind N, Dekker M, Berns A, Radman M, te Riele H (July 1995). ["Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer"](https://doi.org/10.1016%2F0092-8674%2895%2990319-4). *Cell*. **82** (2): 321–30. [doi](/source/Doi_(identifier)):[10.1016/0092-8674(95)90319-4](https://doi.org/10.1016%2F0092-8674%2895%2990319-4). [PMID](/source/PMID_(identifier)) [7628020](https://pubmed.ncbi.nlm.nih.gov/7628020). [S2CID](/source/S2CID_(identifier)) [7954019](https://api.semanticscholar.org/CorpusID:7954019).

1. ^ [***a***](#cite_ref-Pitsikas_7-0) [***b***](#cite_ref-Pitsikas_7-1) Pitsikas P, Lee D, Rainbow AJ (May 2007). ["Reduced host cell reactivation of oxidative DNA damage in human cells deficient in the mismatch repair gene hMSH2"](https://doi.org/10.1093%2Fmutage%2Fgem008). *Mutagenesis*. **22** (3): 235–43. [doi](/source/Doi_(identifier)):[10.1093/mutage/gem008](https://doi.org/10.1093%2Fmutage%2Fgem008). [PMID](/source/PMID_(identifier)) [17351251](https://pubmed.ncbi.nlm.nih.gov/17351251).

1. **[^](#cite_ref-Šimčíková_2019_-_supplementary_table_S7_8-0)** Šimčíková D, Heneberg P (December 2019). ["Refinement of evolutionary medicine predictions based on clinical evidence for the manifestations of Mendelian diseases"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901466). *Scientific Reports*. **9** (1) 18577. [Bibcode](/source/Bibcode_(identifier)):[2019NatSR...918577S](https://ui.adsabs.harvard.edu/abs/2019NatSR...918577S). [doi](/source/Doi_(identifier)):[10.1038/s41598-019-54976-4](https://doi.org/10.1038%2Fs41598-019-54976-4). [PMC](/source/PMC_(identifier)) [6901466](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901466). [PMID](/source/PMID_(identifier)) [31819097](https://pubmed.ncbi.nlm.nih.gov/31819097).

1. **[^](#cite_ref-pmid11852992_9-0)** Müller A, Fishel R (2002). "Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC)". *Cancer Invest*. **20** (1): 102–9. [doi](/source/Doi_(identifier)):[10.1081/cnv-120000371](https://doi.org/10.1081%2Fcnv-120000371). [PMID](/source/PMID_(identifier)) [11852992](https://pubmed.ncbi.nlm.nih.gov/11852992). [S2CID](/source/S2CID_(identifier)) [3581304](https://api.semanticscholar.org/CorpusID:3581304).

1. **[^](#cite_ref-pmid17531815_10-0)** Warren JJ, Pohlhaus TJ, Changela A, Iyer RR, Modrich PL, Beese LS (May 2007). ["Structure of the human MutSalpha DNA lesion recognition complex"](https://doi.org/10.1016%2Fj.molcel.2007.04.018). *Mol. Cell*. **26** (4): 579–92. [doi](/source/Doi_(identifier)):[10.1016/j.molcel.2007.04.018](https://doi.org/10.1016%2Fj.molcel.2007.04.018). [PMID](/source/PMID_(identifier)) [17531815](https://pubmed.ncbi.nlm.nih.gov/17531815).

1. **[^](#cite_ref-pmid17764220_11-0)** Bonis PA, Trikalinos TA, Chung M, Chew P, Ip S, DeVine DA, Lau J (May 2007). ["Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781224). *Evid Rep Technol Assess (Full Rep)* (150): 1–180. [PMC](/source/PMC_(identifier)) [4781224](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781224). [PMID](/source/PMID_(identifier)) [17764220](https://pubmed.ncbi.nlm.nih.gov/17764220).

1. **[^](#cite_ref-pmid23556052_12-0)** Zhang X, Li J (February 2013). ["Era of universal testing of microsatellite instability in colorectal cancer"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613766). *World J Gastrointest Oncol*. **5** (2): 12–9. [doi](/source/Doi_(identifier)):[10.4251/wjgo.v5.i2.12](https://doi.org/10.4251%2Fwjgo.v5.i2.12). [PMC](/source/PMC_(identifier)) [3613766](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613766). [PMID](/source/PMID_(identifier)) [23556052](https://pubmed.ncbi.nlm.nih.gov/23556052).

1. **[^](#cite_ref-pmid20089866_13-0)** Hargreaves VV, Shell SS, Mazur DJ, Hess MT, Kolodner RD (March 2010). ["Interaction between the Msh2 and Msh6 nucleotide-binding sites in the Saccharomyces cerevisiae Msh2-Msh6 complex"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838348). *J. Biol. Chem*. **285** (12): 9301–10. [doi](/source/Doi_(identifier)):[10.1074/jbc.M109.096388](https://doi.org/10.1074%2Fjbc.M109.096388). [PMC](/source/PMC_(identifier)) [2838348](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838348). [PMID](/source/PMID_(identifier)) [20089866](https://pubmed.ncbi.nlm.nih.gov/20089866).

1. **[^](#cite_ref-pmid7604264_14-0)** Drummond JT, Li GM, Longley MJ, Modrich P (June 1995). "Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells". *Science*. **268** (5219): 1909–12. [Bibcode](/source/Bibcode_(identifier)):[1995Sci...268.1909D](https://ui.adsabs.harvard.edu/abs/1995Sci...268.1909D). [doi](/source/Doi_(identifier)):[10.1126/science.7604264](https://doi.org/10.1126%2Fscience.7604264). [PMID](/source/PMID_(identifier)) [7604264](https://pubmed.ncbi.nlm.nih.gov/7604264).

1. **[^](#cite_ref-pmid10954713_15-0)** Christmann M, Kaina B (November 2000). ["Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells to alkylating agents"](https://doi.org/10.1074%2Fjbc.M005377200). *J. Biol. Chem*. **275** (46): 36256–62. [doi](/source/Doi_(identifier)):[10.1074/jbc.M005377200](https://doi.org/10.1074%2Fjbc.M005377200). [PMID](/source/PMID_(identifier)) [10954713](https://pubmed.ncbi.nlm.nih.gov/10954713).

1. **[^](#cite_ref-pmid23391514_16-0)** Edelbrock MA, Kaliyaperumal S, Williams KJ (February 2013). ["Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activities"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659183). *Mutat. Res*. 743–744: 53–66. [doi](/source/Doi_(identifier)):[10.1016/j.mrfmmm.2012.12.008](https://doi.org/10.1016%2Fj.mrfmmm.2012.12.008). [PMC](/source/PMC_(identifier)) [3659183](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659183). [PMID](/source/PMID_(identifier)) [23391514](https://pubmed.ncbi.nlm.nih.gov/23391514).

1. ^ [***a***](#cite_ref-pmid9774676_17-0) [***b***](#cite_ref-pmid9774676_17-1) [***c***](#cite_ref-pmid9774676_17-2) Guerrette S, Wilson T, Gradia S, Fishel R (November 1998). ["Interactions of human hMSH2 with hMSH3 and hMSH2 with hMSH6: examination of mutations found in hereditary nonpolyposis colorectal cancer"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC109246). *Mol. Cell. Biol*. **18** (11): 6616–23. [doi](/source/Doi_(identifier)):[10.1128/mcb.18.11.6616](https://doi.org/10.1128%2Fmcb.18.11.6616). [PMC](/source/PMC_(identifier)) [109246](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC109246). [PMID](/source/PMID_(identifier)) [9774676](https://pubmed.ncbi.nlm.nih.gov/9774676).

1. **[^](#cite_ref-pmid22505031_18-0)** Qiu R, DeRocco VC, Harris C, Sharma A, Hingorani MM, Erie DA, Weninger KR (May 2012). ["Large conformational changes in MutS during DNA scanning, mismatch recognition and repair signalling"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365432). *EMBO J*. **31** (11): 2528–40. [doi](/source/Doi_(identifier)):[10.1038/emboj.2012.95](https://doi.org/10.1038%2Femboj.2012.95). [PMC](/source/PMC_(identifier)) [3365432](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365432). [PMID](/source/PMID_(identifier)) [22505031](https://pubmed.ncbi.nlm.nih.gov/22505031).

1. **[^](#cite_ref-pmid20421420_19-0)** Dowen JM, Putnam CD, Kolodner RD (July 2010). ["Functional studies and homology modeling of Msh2-Msh3 predict that mispair recognition involves DNA bending and strand separation"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897569). *Mol. Cell. Biol*. **30** (13): 3321–8. [doi](/source/Doi_(identifier)):[10.1128/MCB.01558-09](https://doi.org/10.1128%2FMCB.01558-09). [PMC](/source/PMC_(identifier)) [2897569](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897569). [PMID](/source/PMID_(identifier)) [20421420](https://pubmed.ncbi.nlm.nih.gov/20421420).

1. **[^](#cite_ref-pmid22179786_20-0)** Gupta S, Gellert M, Yang W (January 2012). ["Mechanism of mismatch recognition revealed by human MutSβ bound to unpaired DNA loops"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252464). *Nat. Struct. Mol. Biol*. **19** (1): 72–8. [doi](/source/Doi_(identifier)):[10.1038/nsmb.2175](https://doi.org/10.1038%2Fnsmb.2175). [PMC](/source/PMC_(identifier)) [3252464](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252464). [PMID](/source/PMID_(identifier)) [22179786](https://pubmed.ncbi.nlm.nih.gov/22179786).

1. ^ [***a***](#cite_ref-Smith2007_21-0) [***b***](#cite_ref-Smith2007_21-1) Smith JA, Bannister LA, Bhattacharjee V, Wang Y, Waldman BC, Waldman AS (November 2007). ["Accurate homologous recombination is a prominent double-strand break repair pathway in mammalian chromosomes and is modulated by mismatch repair protein Msh2"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169143). *Mol Cell Biol*. **27** (22): 7816–27. [doi](/source/Doi_(identifier)):[10.1128/MCB.00455-07](https://doi.org/10.1128%2FMCB.00455-07). [PMC](/source/PMC_(identifier)) [2169143](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2169143). [PMID](/source/PMID_(identifier)) [17846123](https://pubmed.ncbi.nlm.nih.gov/17846123).

1. ^ [***a***](#cite_ref-pmid14657349_22-0) [***b***](#cite_ref-pmid14657349_22-1) [***c***](#cite_ref-pmid14657349_22-2) Wang Y, Qin J (December 2003). ["MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC307577). *Proc. Natl. Acad. Sci. U.S.A*. **100** (26): 15387–92. [Bibcode](/source/Bibcode_(identifier)):[2003PNAS..10015387W](https://ui.adsabs.harvard.edu/abs/2003PNAS..10015387W). [doi](/source/Doi_(identifier)):[10.1073/pnas.2536810100](https://doi.org/10.1073%2Fpnas.2536810100). [PMC](/source/PMC_(identifier)) [307577](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC307577). [PMID](/source/PMID_(identifier)) [14657349](https://pubmed.ncbi.nlm.nih.gov/14657349).

1. **[^](#cite_ref-pmid11498787_23-0)** Wang Q, Zhang H, Guerrette S, Chen J, Mazurek A, Wilson T, Slupianek A, Skorski T, Fishel R, Greene MI (August 2001). ["Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1"](https://doi.org/10.1038%2Fsj.onc.1204625). *Oncogene*. **20** (34): 4640–9. [doi](/source/Doi_(identifier)):[10.1038/sj.onc.1204625](https://doi.org/10.1038%2Fsj.onc.1204625). [PMID](/source/PMID_(identifier)) [11498787](https://pubmed.ncbi.nlm.nih.gov/11498787).

1. ^ [***a***](#cite_ref-pmid10783165_24-0) [***b***](#cite_ref-pmid10783165_24-1) Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J (April 2000). ["BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC316544). *Genes Dev*. **14** (8): 927–39. [doi](/source/Doi_(identifier)):[10.1101/gad.14.8.927](https://doi.org/10.1101%2Fgad.14.8.927). [PMC](/source/PMC_(identifier)) [316544](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC316544). [PMID](/source/PMID_(identifier)) [10783165](https://pubmed.ncbi.nlm.nih.gov/10783165).

1. **[^](#cite_ref-pmid15647386_25-0)** Adamson AW, Beardsley DI, Kim WJ, Gao Y, Baskaran R, Brown KD (March 2005). ["Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC551512). *Mol. Biol. Cell*. **16** (3): 1513–26. [doi](/source/Doi_(identifier)):[10.1091/mbc.E04-02-0089](https://doi.org/10.1091%2Fmbc.E04-02-0089). [PMC](/source/PMC_(identifier)) [551512](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC551512). [PMID](/source/PMID_(identifier)) [15647386](https://pubmed.ncbi.nlm.nih.gov/15647386).

1. **[^](#cite_ref-pmid12447371_26-0)** Brown KD, Rathi A, Kamath R, Beardsley DI, Zhan Q, Mannino JL, Baskaran R (January 2003). "The mismatch repair system is required for S-phase checkpoint activation". *Nat. Genet*. **33** (1): 80–4. [doi](/source/Doi_(identifier)):[10.1038/ng1052](https://doi.org/10.1038%2Fng1052). [PMID](/source/PMID_(identifier)) [12447371](https://pubmed.ncbi.nlm.nih.gov/12447371). [S2CID](/source/S2CID_(identifier)) [20616220](https://api.semanticscholar.org/CorpusID:20616220).

1. **[^](#cite_ref-pmid10856833_27-0)** Rasmussen LJ, Rasmussen M, Lee B, Rasmussen AK, Wilson DM, Nielsen FC, Bisgaard HC (June 2000). "Identification of factors interacting with hMSH2 in the fetal liver utilizing the yeast two-hybrid system. In vivo interaction through the C-terminal domains of hEXO1 and hMSH2 and comparative expression analysis". *Mutat. Res*. **460** (1): 41–52. [doi](/source/Doi_(identifier)):[10.1016/S0921-8777(00)00012-4](https://doi.org/10.1016%2FS0921-8777%2800%2900012-4). [PMID](/source/PMID_(identifier)) [10856833](https://pubmed.ncbi.nlm.nih.gov/10856833).

1. **[^](#cite_ref-pmid9788596_28-0)** Schmutte C, Marinescu RC, Sadoff MM, Guerrette S, Overhauser J, Fishel R (October 1998). "Human exonuclease I interacts with the mismatch repair protein hMSH2". *Cancer Res*. **58** (20): 4537–42. [PMID](/source/PMID_(identifier)) [9788596](https://pubmed.ncbi.nlm.nih.gov/9788596).

1. **[^](#cite_ref-pmid11427529_29-0)** Schmutte C, Sadoff MM, Shim KS, Acharya S, Fishel R (August 2001). ["The interaction of DNA mismatch repair proteins with human exonuclease I"](https://doi.org/10.1074%2Fjbc.M102670200). *J. Biol. Chem*. **276** (35): 33011–8. [doi](/source/Doi_(identifier)):[10.1074/jbc.M102670200](https://doi.org/10.1074%2Fjbc.M102670200). [PMID](/source/PMID_(identifier)) [11427529](https://pubmed.ncbi.nlm.nih.gov/11427529).

1. **[^](#cite_ref-pmid12584560_30-0)** Mac Partlin M, Homer E, Robinson H, McCormick CJ, Crouch DH, Durant ST, Matheson EC, Hall AG, Gillespie DA, Brown R (February 2003). ["Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX"](https://doi.org/10.1038%2Fsj.onc.1206252). *Oncogene*. **22** (6): 819–25. [doi](/source/Doi_(identifier)):[10.1038/sj.onc.1206252](https://doi.org/10.1038%2Fsj.onc.1206252). [PMID](/source/PMID_(identifier)) [12584560](https://pubmed.ncbi.nlm.nih.gov/12584560).

1. ^ [***a***](#cite_ref-pmid10029069_31-0) [***b***](#cite_ref-pmid10029069_31-1) Bocker T, Barusevicius A, Snowden T, Rasio D, Guerrette S, Robbins D, Schmidt C, Burczak J, Croce CM, Copeland T, Kovatich AJ, Fishel R (February 1999). "hMSH5: a human MutS homologue that forms a novel heterodimer with hMSH4 and is expressed during spermatogenesis". *Cancer Res*. **59** (4): 816–22. [PMID](/source/PMID_(identifier)) [10029069](https://pubmed.ncbi.nlm.nih.gov/10029069).

1. ^ [***a***](#cite_ref-pmid8942985_32-0) [***b***](#cite_ref-pmid8942985_32-1) Acharya S, Wilson T, Gradia S, Kane MF, Guerrette S, Marsischky GT, Kolodner R, Fishel R (November 1996). ["hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC19374). *Proc. Natl. Acad. Sci. U.S.A*. **93** (24): 13629–34. [Bibcode](/source/Bibcode_(identifier)):[1996PNAS...9313629A](https://ui.adsabs.harvard.edu/abs/1996PNAS...9313629A). [doi](/source/Doi_(identifier)):[10.1073/pnas.93.24.13629](https://doi.org/10.1073%2Fpnas.93.24.13629). [PMC](/source/PMC_(identifier)) [19374](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC19374). [PMID](/source/PMID_(identifier)) [8942985](https://pubmed.ncbi.nlm.nih.gov/8942985).

1. **[^](#cite_ref-pmid8630028_33-0)** Scherer SJ, Welter C, Zang KD, Dooley S (April 1996). "Specific in vitro binding of p53 to the promoter region of the human mismatch repair gene hMSH2". *Biochem. Biophys. Res. Commun*. **221** (3): 722–8. [doi](/source/Doi_(identifier)):[10.1006/bbrc.1996.0663](https://doi.org/10.1006%2Fbbrc.1996.0663). [PMID](/source/PMID_(identifier)) [8630028](https://pubmed.ncbi.nlm.nih.gov/8630028).

1. **[^](#cite_ref-pmid18403632_34-0)** Kastan MB (April 2008). ["DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture"](https://doi.org/10.1158%2F1541-7786.MCR-08-0020). *Molecular Cancer Research*. **6** (4): 517–24. [doi](/source/Doi_(identifier)):[10.1158/1541-7786.MCR-08-0020](https://doi.org/10.1158%2F1541-7786.MCR-08-0020). [PMID](/source/PMID_(identifier)) [18403632](https://pubmed.ncbi.nlm.nih.gov/18403632).

1. **[^](#cite_ref-pmid18082599_35-0)** Harper JW, Elledge SJ (December 2007). ["The DNA damage response: ten years after"](https://doi.org/10.1016%2Fj.molcel.2007.11.015). *Molecular Cell*. **28** (5): 739–45. [doi](/source/Doi_(identifier)):[10.1016/j.molcel.2007.11.015](https://doi.org/10.1016%2Fj.molcel.2007.11.015). [PMID](/source/PMID_(identifier)) [18082599](https://pubmed.ncbi.nlm.nih.gov/18082599).

1. **[^](#cite_ref-pmid25451105_36-0)** Dietlein F, Reinhardt HC (December 2014). "Molecular pathways: exploiting tumor-specific molecular defects in DNA repair pathways for precision cancer therapy". *Clinical Cancer Research*. **20** (23): 5882–7. [doi](/source/Doi_(identifier)):[10.1158/1078-0432.CCR-14-1165](https://doi.org/10.1158%2F1078-0432.CCR-14-1165). [PMID](/source/PMID_(identifier)) [25451105](https://pubmed.ncbi.nlm.nih.gov/25451105). [S2CID](/source/S2CID_(identifier)) [16005088](https://api.semanticscholar.org/CorpusID:16005088).

1. **[^](#cite_ref-Hagan_37-0)** O'Hagan HM, Mohammad HP, Baylin SB (2008). ["Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491723). *PLOS Genetics*. **4** (8) e1000155. [doi](/source/Doi_(identifier)):[10.1371/journal.pgen.1000155](https://doi.org/10.1371%2Fjournal.pgen.1000155). [PMC](/source/PMC_(identifier)) [2491723](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491723). [PMID](/source/PMID_(identifier)) [18704159](https://pubmed.ncbi.nlm.nih.gov/18704159).

1. **[^](#cite_ref-Cuozzo_38-0)** Cuozzo C, Porcellini A, Angrisano T, Morano A, Lee B, Di Pardo A, Messina S, Iuliano R, Fusco A, Santillo MR, Muller MT, Chiariotti L, Gottesman ME, Avvedimento EV (July 2007). ["DNA damage, homology-directed repair, and DNA methylation"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913100). *PLOS Genetics*. **3** (7) e110. [doi](/source/Doi_(identifier)):[10.1371/journal.pgen.0030110](https://doi.org/10.1371%2Fjournal.pgen.0030110). [PMC](/source/PMC_(identifier)) [1913100](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913100). [PMID](/source/PMID_(identifier)) [17616978](https://pubmed.ncbi.nlm.nih.gov/17616978). (Retracted, see [doi](/source/Doi_(identifier)):[10.1371/journal.pgen.1011921](https://doi.org/10.1371%2Fjournal.pgen.1011921), [PMID](/source/PMID_(identifier)) [41144352](https://pubmed.ncbi.nlm.nih.gov/41144352), [*Retraction Watch*](https://retractionwatch.com/2018/12/24/alfredo-fusco-facing-misconduct-charges-in-italy-up-to-21-retractions/). If this is an intentional citation to a retracted paper, please replace {{[retracted](https://en.wikipedia.org/wiki/Template:Retracted)|...}} with {{[retracted](https://en.wikipedia.org/wiki/Template:Retracted)|...|intentional=yes}}.)

1. ^ [***a***](#cite_ref-WangYC_39-0) [***b***](#cite_ref-WangYC_39-1) [***c***](#cite_ref-WangYC_39-2) Wang YC, Lu YP, Tseng RC, Lin RK, Chang JW, Chen JT, Shih CM, Chen CY (2003). ["Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC153761). *J. Clin. Invest*. **111** (6): 887–95. [doi](/source/Doi_(identifier)):[10.1172/JCI15475](https://doi.org/10.1172%2FJCI15475). [PMC](/source/PMC_(identifier)) [153761](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC153761). [PMID](/source/PMID_(identifier)) [12639995](https://pubmed.ncbi.nlm.nih.gov/12639995).

1. ^ [***a***](#cite_ref-Diouf_40-0) [***b***](#cite_ref-Diouf_40-1) Diouf B, Cheng Q, Krynetskaia NF, Yang W, Cheok M, Pei D, Fan Y, Cheng C, Krynetskiy EY, Geng H, Chen S, Thierfelder WE, Mullighan CG, Downing JR, Hsieh P, Pui CH, Relling MV, Evans WE (2011). ["Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192247). *Nat. Med*. **17** (10): 1298–303. [doi](/source/Doi_(identifier)):[10.1038/nm.2430](https://doi.org/10.1038%2Fnm.2430). [PMC](/source/PMC_(identifier)) [3192247](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192247). [PMID](/source/PMID_(identifier)) [21946537](https://pubmed.ncbi.nlm.nih.gov/21946537).

1. ^ [***a***](#cite_ref-WangCX_41-0) [***b***](#cite_ref-WangCX_41-1) [***c***](#cite_ref-WangCX_41-2) Wang CX, Wang X, Liu HB, Zhou ZH (2014). ["Aberrant DNA methylation and epigenetic inactivation of hMSH2 decrease overall survival of acute lymphoblastic leukemia patients via modulating cell cycle and apoptosis"](https://doi.org/10.7314%2Fapjcp.2014.15.1.355). *Asian Pac. J. Cancer Prev*. **15** (1): 355–62. [doi](/source/Doi_(identifier)):[10.7314/apjcp.2014.15.1.355](https://doi.org/10.7314%2Fapjcp.2014.15.1.355). [PMID](/source/PMID_(identifier)) [24528056](https://pubmed.ncbi.nlm.nih.gov/24528056).

1. ^ [***a***](#cite_ref-Ling2011_42-0) [***b***](#cite_ref-Ling2011_42-1) Ling ZQ, Li P, Ge MH, Hu FJ, Fang XH, Dong ZM, Mao WM (2011). "Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer". *Dig. Dis. Sci*. **56** (10): 2992–3004. [doi](/source/Doi_(identifier)):[10.1007/s10620-011-1774-z](https://doi.org/10.1007%2Fs10620-011-1774-z). [PMID](/source/PMID_(identifier)) [21674174](https://pubmed.ncbi.nlm.nih.gov/21674174). [S2CID](/source/S2CID_(identifier)) [22913110](https://api.semanticscholar.org/CorpusID:22913110).

1. ^ [***a***](#cite_ref-Hsu_43-0) [***b***](#cite_ref-Hsu_43-1) Hsu HS, Wen CK, Tang YA, Lin RK, Li WY, Hsu WH, Wang YC (2005). "Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer". *Clin. Cancer Res*. **11** (15): 5410–6. [doi](/source/Doi_(identifier)):[10.1158/1078-0432.CCR-05-0601](https://doi.org/10.1158%2F1078-0432.CCR-05-0601). [PMID](/source/PMID_(identifier)) [16061855](https://pubmed.ncbi.nlm.nih.gov/16061855). [S2CID](/source/S2CID_(identifier)) [14444548](https://api.semanticscholar.org/CorpusID:14444548).

1. ^ [***a***](#cite_ref-Lee_44-0) [***b***](#cite_ref-Lee_44-1) Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH (2011). "Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence". *Langenbecks Arch Surg*. **396** (7): 1017–26. [doi](/source/Doi_(identifier)):[10.1007/s00423-011-0812-9](https://doi.org/10.1007%2Fs00423-011-0812-9). [PMID](/source/PMID_(identifier)) [21706233](https://pubmed.ncbi.nlm.nih.gov/21706233). [S2CID](/source/S2CID_(identifier)) [8069716](https://api.semanticscholar.org/CorpusID:8069716).

1. **[^](#cite_ref-pmid12810667_45-0)** Villemure JF, Abaji C, Cousineau I, Belmaaza A (2003). "MSH2-deficient human cells exhibit a defect in the accurate termination of homology-directed repair of DNA double-strand breaks". *Cancer Res*. **63** (12): 3334–9. [PMID](/source/PMID_(identifier)) [12810667](https://pubmed.ncbi.nlm.nih.gov/12810667).

1. **[^](#cite_ref-pmid11283247_46-0)** Elliott B, Jasin M (2001). ["Repair of double-strand breaks by homologous recombination in mismatch repair-defective mammalian cells"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC86898). *Mol. Cell. Biol*. **21** (8): 2671–82. [doi](/source/Doi_(identifier)):[10.1128/MCB.21.8.2671-2682.2001](https://doi.org/10.1128%2FMCB.21.8.2671-2682.2001). [PMC](/source/PMC_(identifier)) [86898](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC86898). [PMID](/source/PMID_(identifier)) [11283247](https://pubmed.ncbi.nlm.nih.gov/11283247).

1. **[^](#cite_ref-pmid22378480_47-0)** Stoehr C, Burger M, Stoehr R, Bertz S, Ruemmele P, Hofstaedter F, Denzinger S, Wieland WF, Hartmann A, Walter B (2012). ["Mismatch repair proteins hMLH1 and hMSH2 are differently expressed in the three main subtypes of sporadic renal cell carcinoma"](https://opus4.kobv.de/opus4-fau/files/3401/PAT2012079003162.pdf) (PDF). *Pathobiology*. **79** (3): 162–8. [doi](/source/Doi_(identifier)):[10.1159/000335642](https://doi.org/10.1159%2F000335642). [PMID](/source/PMID_(identifier)) [22378480](https://pubmed.ncbi.nlm.nih.gov/22378480). [S2CID](/source/S2CID_(identifier)) [26687941](https://api.semanticscholar.org/CorpusID:26687941).[*[permanent dead link](https://en.wikipedia.org/wiki/Wikipedia:Link_rot)*]

1. **[^](#cite_ref-pmid25295100_48-0)** Yoo KH, Won KY, Lim SJ, Park YK, Chang SG (2014). ["Deficiency of MSH2 expression is associated with clear cell renal cell carcinoma"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186615). *Oncol Lett*. **8** (5): 2135–2139. [doi](/source/Doi_(identifier)):[10.3892/ol.2014.2482](https://doi.org/10.3892%2Fol.2014.2482). [PMC](/source/PMC_(identifier)) [4186615](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186615). [PMID](/source/PMID_(identifier)) [25295100](https://pubmed.ncbi.nlm.nih.gov/25295100).

1. **[^](#cite_ref-pmid22265839_49-0)** Ling ZQ, Zhao Q, Zhou SL, Mao WM (2012). "MSH2 promoter hypermethylation in circulating tumor DNA is a valuable predictor of disease-free survival for patients with esophageal squamous cell carcinoma". *Eur J Surg Oncol*. **38** (4): 326–32. [doi](/source/Doi_(identifier)):[10.1016/j.ejso.2012.01.008](https://doi.org/10.1016%2Fj.ejso.2012.01.008). [PMID](/source/PMID_(identifier)) [22265839](https://pubmed.ncbi.nlm.nih.gov/22265839).

1. **[^](#cite_ref-pmid17219447_50-0)** Sengupta S, Chakrabarti S, Roy A, Panda CK, Roychoudhury S (2007). "Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype". *Cancer*. **109** (4): 703–12. [doi](/source/Doi_(identifier)):[10.1002/cncr.22430](https://doi.org/10.1002%2Fcncr.22430). [PMID](/source/PMID_(identifier)) [17219447](https://pubmed.ncbi.nlm.nih.gov/17219447). [S2CID](/source/S2CID_(identifier)) [20191692](https://api.semanticscholar.org/CorpusID:20191692). (This paper currently has an [expression of concern](/source/Expression_of_concern), see [doi](/source/Doi_(identifier)):[10.1002/cncr.35645](https://doi.org/10.1002%2Fcncr.35645), [PMID](/source/PMID_(identifier)) [39558863](https://pubmed.ncbi.nlm.nih.gov/39558863). If this is an intentional citation to a such a paper, please replace {{[expression of concern](https://en.wikipedia.org/wiki/Template:Expression_of_concern)|...}} with {{[expression of concern](https://en.wikipedia.org/wiki/Template:Expression_of_concern)|...|intentional=yes}}.)

1. **[^](#cite_ref-pmid16569647_51-0)** Demokan S, Suoglu Y, Demir D, Gozeler M, Dalay N (2006). ["Microsatellite instability and methylation of the DNA mismatch repair genes in head and neck cancer"](https://doi.org/10.1093%2Fannonc%2Fmdl048). *Ann. Oncol*. **17** (6): 995–9. [doi](/source/Doi_(identifier)):[10.1093/annonc/mdl048](https://doi.org/10.1093%2Fannonc%2Fmdl048). [PMID](/source/PMID_(identifier)) [16569647](https://pubmed.ncbi.nlm.nih.gov/16569647).

1. **[^](#cite_ref-pmid19207881_52-0)** Czerninski R, Krichevsky S, Ashhab Y, Gazit D, Patel V, Ben-Yehuda D (2009). "Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma". *Oral Dis*. **15** (3): 206–13. [doi](/source/Doi_(identifier)):[10.1111/j.1601-0825.2008.01510.x](https://doi.org/10.1111%2Fj.1601-0825.2008.01510.x). [PMID](/source/PMID_(identifier)) [19207881](https://pubmed.ncbi.nlm.nih.gov/19207881).

1. **[^](#cite_ref-pmid24400091_53-0)** Hinrichsen I, Kemp M, Peveling-Oberhag J, Passmann S, Plotz G, Zeuzem S, Brieger A (2014). ["Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882222). *PLOS ONE*. **9** (1) e84453. [Bibcode](/source/Bibcode_(identifier)):[2014PLoSO...984453H](https://ui.adsabs.harvard.edu/abs/2014PLoSO...984453H). [doi](/source/Doi_(identifier)):[10.1371/journal.pone.0084453](https://doi.org/10.1371%2Fjournal.pone.0084453). [PMC](/source/PMC_(identifier)) [3882222](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882222). [PMID](/source/PMID_(identifier)) [24400091](https://pubmed.ncbi.nlm.nih.gov/24400091).

1. **[^](#cite_ref-pmid21766496_54-0)** Vlaykova T, Mitkova A, Stancheva G, Kadiyska T, Gulubova M, Yovchev Y, Cirovski G, Chilingirov P, Damyanov D, Kremensky I, Mitev V, Kaneva R (2011). "Microsatellite instability and promoter hypermethylation of MLH1 and MSH2 in patients with sporadic colorectal cancer". *J BUON*. **16** (2): 265–73. [PMID](/source/PMID_(identifier)) [21766496](https://pubmed.ncbi.nlm.nih.gov/21766496).

1. **[^](#cite_ref-pmid24317816_55-0)** Malhotra P, Anwar M, Kochhar R, Ahmad S, Vaiphei K, Mahmood S (2014). "Promoter methylation and immunohistochemical expression of hMLH1 and hMSH2 in sporadic colorectal cancer: a study from India". *Tumour Biol*. **35** (4): 3679–87. [doi](/source/Doi_(identifier)):[10.1007/s13277-013-1487-3](https://doi.org/10.1007%2Fs13277-013-1487-3). [PMID](/source/PMID_(identifier)) [24317816](https://pubmed.ncbi.nlm.nih.gov/24317816). [S2CID](/source/S2CID_(identifier)) [10615946](https://api.semanticscholar.org/CorpusID:10615946).

1. **[^](#cite_ref-pmid24052709_56-0)** Onrat S, Ceken I, Ellidokuz E, Kupelioğlu A (2011). ["Alterations of copy number of methylation pattern in mismatch repair genes by methylation specific-multiplex ligation-dependent probe amplification in cases of colon cancer"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776700). *Balkan J. Med. Genet*. **14** (2): 25–34. [doi](/source/Doi_(identifier)):[10.2478/v10034-011-0044-x](https://doi.org/10.2478%2Fv10034-011-0044-x). [PMC](/source/PMC_(identifier)) [3776700](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776700). [PMID](/source/PMID_(identifier)) [24052709](https://pubmed.ncbi.nlm.nih.gov/24052709).

1. **[^](#cite_ref-pmid16258501_57-0)** Kawaguchi K, Oda Y, Saito T, Yamamoto H, Takahira T, Kobayashi C, Tamiya S, Tateishi N, Iwamoto Y, Tsuneyoshi M (2006). ["DNA hypermethylation status of multiple genes in soft tissue sarcomas"](https://doi.org/10.1038%2Fmodpathol.3800502). *Mod. Pathol*. **19** (1): 106–14. [doi](/source/Doi_(identifier)):[10.1038/modpathol.3800502](https://doi.org/10.1038%2Fmodpathol.3800502). [PMID](/source/PMID_(identifier)) [16258501](https://pubmed.ncbi.nlm.nih.gov/16258501).

## Further reading

- Jiricny J (1994). "Colon cancer and DNA repair: have mismatches met their match?". *Trends Genet*. **10** (5): 164–8. [doi](/source/Doi_(identifier)):[10.1016/0168-9525(94)90093-0](https://doi.org/10.1016%2F0168-9525%2894%2990093-0). [PMID](/source/PMID_(identifier)) [8036718](https://pubmed.ncbi.nlm.nih.gov/8036718).

- Fishel R, Wilson T (1997). "MutS homologs in mammalian cells". *Curr. Opin. Genet. Dev*. **7** (1): 105–13. [doi](/source/Doi_(identifier)):[10.1016/S0959-437X(97)80117-7](https://doi.org/10.1016%2FS0959-437X%2897%2980117-7). [PMID](/source/PMID_(identifier)) [9024626](https://pubmed.ncbi.nlm.nih.gov/9024626).

- Lothe RA (1997). "Microsatellite instability in human solid tumors". *Molecular Medicine Today*. **3** (2): 61–8. [doi](/source/Doi_(identifier)):[10.1016/S1357-4310(96)10055-1](https://doi.org/10.1016%2FS1357-4310%2896%2910055-1). [PMID](/source/PMID_(identifier)) [9060003](https://pubmed.ncbi.nlm.nih.gov/9060003).

- Peltomäki P, de la Chapelle A (1997). "Mutations predisposing to hereditary nonpolyposis colorectal cancer". *Adv. Cancer Res*. Advances in Cancer Research. **71**: 93–119. [doi](/source/Doi_(identifier)):[10.1016/S0065-230X(08)60097-4](https://doi.org/10.1016%2FS0065-230X%2808%2960097-4). [ISBN](/source/ISBN_(identifier)) [978-0-12-006671-1](https://en.wikipedia.org/wiki/Special:BookSources/978-0-12-006671-1). [PMID](/source/PMID_(identifier)) [9111864](https://pubmed.ncbi.nlm.nih.gov/9111864).

- Papadopoulos N, Lindblom A (1997). "Molecular basis of HNPCC: mutations of MMR genes". *Hum. Mutat*. **10** (2): 89–99. [doi](/source/Doi_(identifier)):[10.1002/(SICI)1098-1004(1997)10:2<89::AID-HUMU1>3.0.CO;2-H](https://doi.org/10.1002%2F%28SICI%291098-1004%281997%2910%3A2%3C89%3A%3AAID-HUMU1%3E3.0.CO%3B2-H). [PMID](/source/PMID_(identifier)) [9259192](https://pubmed.ncbi.nlm.nih.gov/9259192). [S2CID](/source/S2CID_(identifier)) [6799575](https://api.semanticscholar.org/CorpusID:6799575).

- Kauh J, Umbreit J (2004). "Colorectal cancer prevention". *Current Problems in Cancer*. **28** (5): 240–64. [doi](/source/Doi_(identifier)):[10.1016/j.currproblcancer.2004.05.004](https://doi.org/10.1016%2Fj.currproblcancer.2004.05.004). [PMID](/source/PMID_(identifier)) [15375803](https://pubmed.ncbi.nlm.nih.gov/15375803).

- Warusavitarne J, Schnitzler M (2007). "The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer". *International Journal of Colorectal Disease*. **22** (7): 739–48. [doi](/source/Doi_(identifier)):[10.1007/s00384-006-0228-0](https://doi.org/10.1007%2Fs00384-006-0228-0). [PMID](/source/PMID_(identifier)) [17109103](https://pubmed.ncbi.nlm.nih.gov/17109103). [S2CID](/source/S2CID_(identifier)) [6460105](https://api.semanticscholar.org/CorpusID:6460105).

- Wei Q, Xu X, Cheng L, et al. (1995). "Simultaneous amplification of four DNA repair genes and beta-actin in human lymphocytes by multiplex reverse transcriptase-PCR". *Cancer Res*. **55** (21): 5025–9. [PMID](/source/PMID_(identifier)) [7585546](https://pubmed.ncbi.nlm.nih.gov/7585546).

- Wilson TM, Ewel A, Duguid JR, et al. (1995). "Differential cellular expression of the human MSH2 repair enzyme in small and large intestine". *Cancer Res*. **55** (22): 5146–50. [PMID](/source/PMID_(identifier)) [7585562](https://pubmed.ncbi.nlm.nih.gov/7585562).

- Drummond JT, Li GM, Longley MJ, Modrich P (1995). "Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells". *Science*. **268** (5219): 1909–12. [Bibcode](/source/Bibcode_(identifier)):[1995Sci...268.1909D](https://ui.adsabs.harvard.edu/abs/1995Sci...268.1909D). [doi](/source/Doi_(identifier)):[10.1126/science.7604264](https://doi.org/10.1126%2Fscience.7604264). [PMID](/source/PMID_(identifier)) [7604264](https://pubmed.ncbi.nlm.nih.gov/7604264).

- Kolodner RD, Hall NR, Lipford J, et al. (1995). "Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations". *Genomics*. **24** (3): 516–26. [doi](/source/Doi_(identifier)):[10.1006/geno.1994.1661](https://doi.org/10.1006%2Fgeno.1994.1661). [PMID](/source/PMID_(identifier)) [7713503](https://pubmed.ncbi.nlm.nih.gov/7713503).

- Wijnen J, Vasen H, Khan PM, et al. (1995). ["Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1801472). *Am. J. Hum. Genet*. **56** (5): 1060–6. [PMC](/source/PMC_(identifier)) [1801472](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1801472). [PMID](/source/PMID_(identifier)) [7726159](https://pubmed.ncbi.nlm.nih.gov/7726159).

- Mary JL, Bishop T, Kolodner R, et al. (1995). "Mutational analysis of the hMSH2 gene reveals a three base pair deletion in a family predisposed to colorectal cancer development". *Hum. Mol. Genet*. **3** (11): 2067–9. [PMID](/source/PMID_(identifier)) [7874129](https://pubmed.ncbi.nlm.nih.gov/7874129).

- Fishel R, Ewel A, Lescoe MK (1994). "Purified human MSH2 protein binds to DNA containing mismatched nucleotides". *Cancer Res*. **54** (21): 5539–42. [PMID](/source/PMID_(identifier)) [7923193](https://pubmed.ncbi.nlm.nih.gov/7923193).

- Fishel R, Ewel A, Lee S, et al. (1994). "Binding of mismatched microsatellite DNA sequences by the human MSH2 protein". *Science*. **266** (5189): 1403–5. [Bibcode](/source/Bibcode_(identifier)):[1994Sci...266.1403F](https://ui.adsabs.harvard.edu/abs/1994Sci...266.1403F). [doi](/source/Doi_(identifier)):[10.1126/science.7973733](https://doi.org/10.1126%2Fscience.7973733). [PMID](/source/PMID_(identifier)) [7973733](https://pubmed.ncbi.nlm.nih.gov/7973733).

- Liu B, Parsons RE, Hamilton SR, et al. (1994). "hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds". *Cancer Res*. **54** (17): 4590–4. [PMID](/source/PMID_(identifier)) [8062247](https://pubmed.ncbi.nlm.nih.gov/8062247).

- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". *Gene*. **138** (1–2): 171–4. [doi](/source/Doi_(identifier)):[10.1016/0378-1119(94)90802-8](https://doi.org/10.1016%2F0378-1119%2894%2990802-8). [PMID](/source/PMID_(identifier)) [8125298](https://pubmed.ncbi.nlm.nih.gov/8125298).

- Fishel R, Lescoe MK, Rao MR, et al. (1994). "The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer". *Cell*. **77** (1): 167–169. [doi](/source/Doi_(identifier)):[10.1016/0092-8674(94)90306-9](https://doi.org/10.1016%2F0092-8674%2894%2990306-9). [PMID](/source/PMID_(identifier)) [8156592](https://pubmed.ncbi.nlm.nih.gov/8156592). [S2CID](/source/S2CID_(identifier)) [45905483](https://api.semanticscholar.org/CorpusID:45905483).

- Fishel R, Lescoe MK, Rao MR, et al. (1994). "The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer". *Cell*. **75** (5): 1027–38. [doi](/source/Doi_(identifier)):[10.1016/0092-8674(93)90546-3](https://doi.org/10.1016%2F0092-8674%2893%2990546-3). [PMID](/source/PMID_(identifier)) [8252616](https://pubmed.ncbi.nlm.nih.gov/8252616). [S2CID](/source/S2CID_(identifier)) [46235760](https://api.semanticscholar.org/CorpusID:46235760).

## External links

- [MutS+Homolog+2+Protein](https://meshb.nlm.nih.gov/record/ui?name=MutS+Homolog+2+Protein) at the U.S. National Library of Medicine [Medical Subject Headings](/source/Medical_Subject_Headings) (MeSH)

v t e PDB gallery 2o8b: human MutSalpha (MSH2/MSH6) bound to ADP and a G T mispair 2o8c: human MutSalpha (MSH2/MSH6) bound to ADP and an O6-methyl-guanine T mispair 2o8d: human MutSalpha (MSH2/MSH6) bound to ADP and a G dU mispair 2o8e: human MutSalpha (MSH2/MSH6) bound to a G T mispair, with ADP bound to MSH2 only 2o8f: human MutSalpha (MSH2/MSH6) bound to DNA with a single base T insert

v t e DNA repair Excision repair Base excision repair/AP site DNA glycosylase Uracil-DNA glycosylase Poly ADP ribose polymerase Nucleotide excision repair/ERCC XPA XPB XPC XPD/ERCC2 XPE/DDB1 XPF/DDB1 XPG/ERCC5 ERCC1 RPA RAD23A RAD23B Excinuclease DNA mismatch repair MLH1 MSH2 Homologous recombination RecA RecBCD RecF pathway RecQ helicase RAD51 Sgs1 Slx4 LexA Other pathways Transcription-coupled repair ERCC6 ERCC8 Homology directed repair Non-homologous end joining Ku Microhomology-mediated end joining Postreplication repair Photolyase CRY1 CRY2 Regulation SOS box SOS response Other/ungrouped Ogt PcrA Proliferating Cell Nuclear Antigen 8-Oxoguanine Adaptive response Meiotic recombination checkpoint DNA helicase: BLM WRN FANC proteins: core protein complex FANCA FANCB FANCC FANCE FANCF FANCG FANCL FANCM FANCD1 FANCD2 FANCI FANCJ FANCN Category

---
Adapted from the Wikipedia article [MSH2](https://en.wikipedia.org/wiki/MSH2) by Wikipedia contributors ([contributor history](https://en.wikipedia.org/wiki/MSH2?action=history)). Available under [Creative Commons Attribution-ShareAlike 4.0 International](https://creativecommons.org/licenses/by-sa/4.0/). Changes may have been made.